The Guardian Australia – Business
·business
·1 hour ago
GSK to buy US cancer treatment firm Nuvalent for $10.6bn
GSK to buy US cancer treatment firm Nuvalent for $10.6bn British drugmaker’s new chief executive Luke Miels announces one of its biggest deals Business live – latest updates Business live – latest updates GSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, announcing the $10.6bn (£7.9bn) acquisition of a US cancer specialist with two-late stage.
Summary by Glance · The Guardian Australia – Business
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI